Skip to content

Comparison of Acetate Ringer's Solution Versus Ringer's Lactated Solution for Fluid Resuscitation in Patients with Acute Pancreatitis

Comparison of Acetate Ringer’s Solution Versus Ringer’s Lactated Solution for Fluid Resuscitation in Patients with Acute Pancreatitis

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20170903001
Enrollment
50
Registered
2017-09-03
Start date
2016-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Outpatient who presents with acute pancreatitis. Outpatient&#44

Interventions

Selected population who compatible with inclusion/exclusion criteria&#44
was resuscitated by Lactated Ringer&#39
s Solution followed study protocols and measure primary and secondary outcome after treatment 48 hours.,Selected population who compatible with inclusion/exclusion criteria&#44
was resuscitated by Acetatetated Ringer&#39
s Solution followed study protocols and measure primary and secondary outcome after treatment 48 hours.
Active Comparator Other,Active Comparator Other
Lactated Ringer&#39
s Solution group,Acetated Ringer&#39
s solution group

Sponsors

Gastroenterological association of Thailand
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients aged 18-80 years who were admit with diagnosis of acute pancreatitis. Diagnosis was comfirmed by the presence of 2 or more of the of the following criteria 1) Epigastric abdominal pain. 2) Elevation in serum amylase and/or lipase level greater than 3 times the upper limit of normal. 3) Confirmatory findings on cross-sectional imaging.

Exclusion criteria

Exclusion criteria: Known history of severe cardiovascular&#44; respiratory&#44; renal&#44; hepatic&#44; hematologic or immunologic disease. defined as 1. Aged 80 years or older. 2. Greater than New York Heart Association class II heart failure. 3. Active myocardial ischemia. 4. Cardiovascular intervention within previous 60 days. 5. History of cirrhosis. 6. Chronic kidney disease with creatinine clearance < 40 ml/min. 7. Chronic obstructive pulmonary disease with requirement for home oxygen. 8. Patients with a history of metastasis malignancy. 9. Patients with a history of autoimmune disease include autoimmune pancreatitis.. 10. Chronic infectious disease including HIV and tuberculosis. 11. Patients with infection including cholescystitis and cholangitis. 12. Patients with bowel ischemia and bowel perforation. 13. Patients with hypercalcemia. 14. Sepsis (presence of suspected or confirmed infection in setting of SIRS) 15. Rhabdomyolysis. 16. Post&#45;intervention pancreatitis. 17. Severe pancreatitis.

Design outcomes

Primary

MeasureTime frame
SIRs (systemic inflamatory response) ratio at 48 hours after treatment 48 hours Comparison SIRs reduction at 48 hours after treatment in acute pancreatitis patient between Lactated

Secondary

MeasureTime frame
Response of inflammatory marker in acute pancreatitis patient. 48 hours Comparison inflamatory marker reduction ratio after treatment both groups

Countries

Thailand

Contacts

Public ContactKantapat Volrapimol

Phramongkutklao Hospital

Kantapat.v@hotmail.com081-830-4595

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026